Edition:
United States

Intec Pharma Ltd (NTEC.OQ)

NTEC.OQ on NASDAQ Stock Exchange Capital Market

5.70USD
23 Feb 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.70
Open
$5.70
Day's High
$5.75
Day's Low
$5.55
Volume
5,586
Avg. Vol
23,573
52-wk High
$9.80
52-wk Low
$4.20

Chart for

About

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodyna... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 195.87 16.59
EPS (TTM): -- -- --
ROI: -- -0.71 35.07
ROE: -- -3.37 17.79

BRIEF-Meitav Dash Investments Ltd Group Reports 7.18 Pct Passive Stake In Intec Pharma

* MEITAV DASH INVESTMENTS LTD GROUP REPORTS 7.18 PERCENT PASSIVE STAKE IN INTEC PHARMA LTD AS OF DECEMBER 31 - SEC FILING Source text: (http://bit.ly/2D867LN) Further company coverage:

Jan 08 2018

BRIEF-Intec Pharma reports Q3 earnings per share $0.40

* Intec Pharma reports third quarter 2017 operating and financial results

Nov 15 2017

BRIEF-Acuta Capital Partners reports 10.5 pct passive stake in Intec Pharma

* Acuta Capital Partners reports 10.5 pct passive stake in Intec Pharma Ltd as of Aug 31 - SEC filing Source text: (http://bit.ly/2gRgBs0) Further company coverage:

Sep 08 2017

BRIEF-Adage Capital Partners reports 6.64 pct passive stake in Intec Pharma

* Adage Capital Partners GP LLC reports 6.64 percent passive stake in Intec Pharma Ltd ‍​as of August 16 - sec filing Source text : http://bit.ly/2vvPmop Further company coverage:

Aug 25 2017

Earnings vs. Estimates